Advertisement

Topics

Biogen Idec Inc. Company Profile

20:36 EST 22nd January 2019 | BioPortfolio

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.


News Articles [425 Associated News Articles listed on BioPortfolio]

Nomura wertet Biogen-Studie zu Alzheimer-Wirkstoff psoitiv

Das japanische Analysehaus Nomura hat die Einstufung für Biogen Idec nach positiven Daten zum Wirkstoff BAN2401 gegen Alzheimer auf "Buy" mit einem Kursziel von 420 US-Dollar belassen. Mit den Erg...

Pooled analysis results of adalimumab, etanercept and infliximab biosimilars

South Korean electronics giant Samsung and biotechnology company Biogen Idec (Biogen) joint venture Samsung Bioepis, along with Biogen, announced on 13 June 2018 results of a pooled analysis combining...

Biogen, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Biogen, Inc. Strategy, SWOT and Corporate Finance ReportSummaryBiogen, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers ...

STAT Plus: Here’s why Biogen lost $7 billion overnight despite ‘positive’ Alzheimer’s data

The latest Alzheimer's data from Biogen and its partner Eisai have renewed hopes for an effective treatment. So why has Biogen's stock tanked?

Biogen Inc.: Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions

C4T's targeted protein degradation platform provides a novel approach to neuroscience drug discovery and development, complementing Biogen's broader research and development efforts across multiple...

Biogen: Eines der ersten globalen Biotechnologieunternehmen

Berlin (www.aktiencheck.de) - Biogen-Aktienanalyse von LYNX Broker: Philip Morris von LYXN Broker nimmt in einer aktuellen Aktienanalyse die Aktie des US-Biotechkonzerns Biogen Inc. (ISIN: US09062X...

MSD signs $117m deal with Samsung Bioepis over Janssen biosimilar

American multinational MSD have won a $117 million contract allowing them to supply Samsung Bioepis’ Renflexis to the US Department of Veteran Affairs. The deal between the multibillion dollar pharm...

Trading-Idee Biogen: Beachtenswertes Biotechnologie-Unternehmen

Biogen ist ein beachtenswertes Biotechnologie-Unternehmen. Daher kommt man im Bereich der Neurowissenschaften um Biogen nicht herum. Insbesondere mit seiner Spezialisierung auf Erkrankungen der Ner...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Tecfidera [Biogen Inc.]

These highlights do not include all the information needed to use TECFIDERA safely and effectively. See full prescribing information for TECFIDERA.TECFIDERA (dimethyl fumarate) delayed-release capsule...

Tysabri [Biogen Inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useIniti...

PubMed Articles [0 Results]

None

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

This is a Phase I/II open-label, dose-escalating study in patients with metastatic colorectal cancer. The objectives of the study are to obtain information on the safety of radiolabeled I...

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

The purpose of this study is to determine whether anti-CD80 monoclonal antibody (IDEC-114) is effective in the treatment of follicular B-cell non-Hodgkin's lymphoma. This drug has never b...

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

To determine what side effects and what clinical effect, if any, the administration of this investigational product, IDEC-114 in combination with Rituxan® [Rituxan® as a single agent is ...

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

The purpose of this study is to see if we can find a new way to test how certain Multiple Sclerosis (MS) medications work in the body and to better understand how the medicines change cert...

Pregnancy Exposure Registry for AVONEX

This is an observational, exposure-registration and follow-up study, which will be conducted in the United States (US). The AVONEX® Pregnancy Exposure Registry is designed to monitor pre...

Companies [34 Associated Companies listed on BioPortfolio]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec and Elan Corporation, plc

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec and Abbott

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Biogen Idec

Scientific excellence that achieves new standards of care drives the company's work. 17 products are currently in clinical development addressing a variety of key medical needs.With patients in more t...

More Information about "Biogen Idec Inc." on BioPortfolio

We have published hundreds of Biogen Idec Inc. news stories on BioPortfolio along with dozens of Biogen Idec Inc. Clinical Trials and PubMed Articles about Biogen Idec Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biogen Idec Inc. Companies in our database. You can also find out about relevant Biogen Idec Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record